These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 14642404)
1. Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery. Nishiguchi F; Fukui R; Hoshiga M; Negoro N; Ii M; Nakakohji T; Kohbayashi E; Ishihara T; Hanafusa T Atherosclerosis; 2003 Nov; 171(1):39-47. PubMed ID: 14642404 [TBL] [Abstract][Full Text] [Related]
2. Role of Rho-associated kinase in neointima formation after vascular injury. Shibata R; Kai H; Seki Y; Kato S; Morimatsu M; Kaibuchi K; Imaizumi T Circulation; 2001 Jan; 103(2):284-9. PubMed ID: 11208690 [TBL] [Abstract][Full Text] [Related]
12. LRP1B attenuates the migration of smooth muscle cells by reducing membrane localization of urokinase and PDGF receptors. Tanaga K; Bujo H; Zhu Y; Kanaki T; Hirayama S; Takahashi K; Inoue M; Mikami K; Schneider WJ; Saito Y Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1422-8. PubMed ID: 15166012 [TBL] [Abstract][Full Text] [Related]
13. Rho-kinase inhibitor suppressed restenosis in porcine coronary balloon angioplasty. Iso Y; Suzuki H; Sato T; Shoji M; Shimizu N; Shibata M; Koba S; Geshi E; Katagiri T Int J Cardiol; 2006 Jan; 106(1):103-10. PubMed ID: 15922466 [TBL] [Abstract][Full Text] [Related]
14. Counter-regulatory function of protein tyrosine phosphatase 1B in platelet-derived growth factor- or fibroblast growth factor-induced motility and proliferation of cultured smooth muscle cells and in neointima formation. Chang Y; Ceacareanu B; Zhuang D; Zhang C; Pu Q; Ceacareanu AC; Hassid A Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):501-7. PubMed ID: 16373608 [TBL] [Abstract][Full Text] [Related]
15. Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya disease. Yamamoto M; Aoyagi M; Fukai N; Matsushima Y; Yamamoto K Stroke; 1998 Jun; 29(6):1188-93. PubMed ID: 9626293 [TBL] [Abstract][Full Text] [Related]
16. A decline in platelet activation and inflammatory cell infiltration is associated with the phenotypic redifferentiation of neointimal smooth muscle cells after bare-metal stent implantation in acute coronary syndrome. Nakagawa M; Naruko T; Ikura Y; Komatsu R; Iwasa Y; Kitabayashi C; Inoue T; Itoh A; Yoshiyama M; Ueda M J Atheroscler Thromb; 2010 Jul; 17(7):675-87. PubMed ID: 20523011 [TBL] [Abstract][Full Text] [Related]
17. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells. Kamiyama M; Utsunomiya K; Taniguchi K; Yokota T; Kurata H; Tajima N; Kondo K J Atheroscler Thromb; 2003; 10(2):117-23. PubMed ID: 12740486 [TBL] [Abstract][Full Text] [Related]
18. Blockade of angio-associated migratory cell protein inhibits smooth muscle cell migration and neointima formation in accelerated atherosclerosis. Vogt F; Zernecke A; Beckner M; Krott N; Bosserhoff AK; Hoffmann R; Zandvoort MA; Jahnke T; Kelm M; Weber C; Blindt R J Am Coll Cardiol; 2008 Jul; 52(4):302-11. PubMed ID: 18634987 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of ML-9, wortmannin, and Y-27632 on the chemotaxis of vascular smooth muscle cells in response to platelet-derived growth factor-BB. Kishi H; Bao J; Kohama K J Biochem; 2000 Nov; 128(5):719-22. PubMed ID: 11056381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]